U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270133) titled 'Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes' on Oct. 07.
Brief Summary: A considerable hurdle to the development of novel, more effective therapies for diabetic retinal disease is the limited number of primary endpoints available for use in regulatory trials. Current endpoints necessitate long trial durations and a greater number of participants to show efficacy. Thus, a better understanding of the structural and functional changes in the retina occurring in people with diabetes is essential for developing primary endpoints and validating surrogate and clinical endpoints.
Study Start Date...